April 26, 2012
1:12-cv-00469
35:146 Appeal of Decision of the Board of Patent Appeals and Interferences
News Coverage, Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
A Virginia federal judge on Wednesday preserved Exela Pharma Sciences LLC's lawsuit alleging the federal government improperly revived a patent related to injectable acetaminophen treatment Ofirmev, a significant victory as the company defends itself in a separate patent infringement case.